Sign in
4

Changes in Ownership

Benitec Biopharma Inc. Filed Acc 0000899140-24-001042

Director acquired 7,137,763 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2024-09-26 Option exercise +588,236 $1.93 $1,135,237 2,058,415 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2024-09-26 Option exercise +4,605,000 $3.86 $17,775,300 6,663,415 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2024-09-26 Option exercise +1,219,970 $0.00 $122 7,883,385 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2024-09-26 Option exercise +576,347 $3.86 $2,224,699 797,458 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2024-09-26 Option exercise +148,210 $0.00 $15 945,668 I
Derivatives
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2024-09-26 Option exercise · Series 2 Common Warrants −10,000,000 0 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2024-09-26 Option exercise · Common Warrants −4,605,000 0 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2024-09-26 Option exercise · Pre-Funded Warrants −1,219,970 3,385,030 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2024-09-26 Option exercise · Common Warrants −576,347 0 I
SUVRETTA CAPITAL MANAGEMENT, LLC Director 2024-09-26 Option exercise · Pre-Funded Warrants −148,210 428,137 I
Loading xslF345X05/form4.xml…